| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $159.9M | — | +43.3% |
| R&D Expense | $97.9M | — | +112.6% |
| SG&A Expense | $96.3M | — | +66.9% |
| Operating Income | -$789.5M | — | -5099.7% |
| Pre-tax Income | -$789.7M | — | -5686.0% |
| Income Tax | $475K | — | -53.8% |
| Net Income | -$790.2M | — | -5283.6% |
| EPS (Basic) | -$13.43 | — | -4376.7% |
| EPS (Diluted) | -$13.43 | — | -4376.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $324.9M | +9.5% | +53.4% |
| Short-term Investments | $61.4M | -29.2% | -6.8% |
| Accounts Receivable | $133.1M | +7.9% | +38.9% |
| Inventory | $25.5M | +2.5% | +13.8% |
| Current Assets | $569.4M | +3.6% | +38.6% |
| Total Assets | $890.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$228.8M | — | — |
| Capital Expenditures | $664K | — | +1519.5% |
| Investing Cash Flow | -$11.6M | — | +28.3% |
| Financing Cash Flow | $270.1M | — | +4147.2% |
| Free Cash Flow | -$229.4M | — | — |
| +29.1% |
| Current Liabilities | $272.8M | +32.6% | +113.9% |
| Total Liabilities | $648.4M | +22.8% | +41.9% |
| Stockholders' Equity | $242.5M | -22.9% | +4.0% |